Title : Hexokinase II inhibition by 3-bromopyruvate sensitizes myeloid leukemic cells K-562 to anti-leukemic drug, daunorubicin.

Pub. Date : 2019 Sep 30

PMID : 31506393






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Hexokinase II inhibition by 3-Bromopyruvate sensitizes myeloid leukemic cells K-562 to anti leukemic drug Daunorubicin. bromopyruvate hexokinase 2 Homo sapiens
2 The HK-II inhibitor 3- Bromopyruvate (3-BP) dissociates HK II from mitochondrial complex, which leads to enhanced sensitization of leukemic cells to anti leukemic drugs. bromopyruvate hexokinase 2 Homo sapiens
3 The HK-II inhibitor 3- Bromopyruvate (3-BP) dissociates HK II from mitochondrial complex, which leads to enhanced sensitization of leukemic cells to anti leukemic drugs. bromopyruvate hexokinase 2 Homo sapiens
4 The HK-II inhibitor 3- Bromopyruvate (3-BP) dissociates HK II from mitochondrial complex, which leads to enhanced sensitization of leukemic cells to anti leukemic drugs. bromopyruvate hexokinase 2 Homo sapiens
5 The HK-II inhibitor 3- Bromopyruvate (3-BP) dissociates HK II from mitochondrial complex, which leads to enhanced sensitization of leukemic cells to anti leukemic drugs. bromopyruvate hexokinase 2 Homo sapiens